Cargando…
Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges
Small GTPases are a family of low molecular weight GTP-hydrolyzing enzymes that cycle between an inactive state when bound to GDP and an active state when associated to GTP. Small GTPases regulate key cellular processes (e.g., cell differentiation, proliferation, and motility) as well as subcellular...
Autores principales: | Prieto-Dominguez, Néstor, Parnell, Christopher, Teng, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468615/ https://www.ncbi.nlm.nih.gov/pubmed/30884855 http://dx.doi.org/10.3390/cells8030255 |
Ejemplares similares
-
GTPase Pathways in Health and Diseases
por: Teng, Yong
Publicado: (2022) -
The role of the small GTPase Rab31 in cancer
por: Chua, Christelle En Lin, et al.
Publicado: (2015) -
Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021) -
Improving radiotherapy in cancer treatment: Promises and challenges
por: Chen, Helen H.W., et al.
Publicado: (2017) -
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance
por: Rio-Vilariño, Anxo, et al.
Publicado: (2021)